Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HZ.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HZ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HZ.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HZ.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HZ.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HZ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HZ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.69EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.69ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.69ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.69EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.69EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.98EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.98EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.98ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.98ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.98EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.98EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.98ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.98ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.71EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.71ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.71ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.71EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.71EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.60EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used